E-LIB Suche - Ergebnisse für: Kevans, D.

1

DOP15 Results of a pragmatic multicentred randomised contro..:

Doherty, G ; Coe, C ; Egan, L...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i99-i99 , 2024

Link: https://doi.org/10.1093/..

2

P041 Assessment of Serum Biomarkers associated with Vedoliz..:

O'Connell, J ; Argue, R ; Dunne, M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i303-i303 , 2024

Link: https://doi.org/10.1093/..

3

P066 Serum amyloid A – A Novel Biomarker of Ulcerative Coli..:

McShane, C ; O'Connell, F ; Corcoran, R...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i336-i336 , 2024

Link: https://doi.org/10.1093/..

4

P552 Clinical factors associated with ustekinumab therapy p..:

Corcoran, R ; Breslin, N ; Ryan, B...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i1087-i1087 , 2024

Link: https://doi.org/10.1093/..

5

P103 Natural compounds in Ulcerative Colitis and Irritable ..:

McShane, C ; O'Connell, F ; Pigott, M...
Journal of Crohn's and Colitis. 18 (2024) Supplement_1 - p. i384-i385 , 2024

Link: https://doi.org/10.1093/..

6

P695 Effectiveness and Safety of Combination Biologic or Sm..:

McShane, C ; Varley, R ; Fennessy, A...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i825-i826 , 2023

Link: https://doi.org/10.1093/..

7

P483 Golimumab response in Ulcerative Colitis as early as w..:

Kumar, L ; O'Morain, N ; Sheridan, J...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i614-i615 , 2023

Link: https://doi.org/10.1093/..

8

P054 Secreted inflammatory protein profiles following treat..:

Corcoran, R ; O'Connell, F ; O'Sullivan, J.
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i221-i222 , 2023

Link: https://doi.org/10.1093/..

9

P089 Colonic explant lactate concentration and inflammatory..:

McShane, C ; Corcoran, R ; O'Connell, F...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i251-i253 , 2023

Link: https://doi.org/10.1093/..

10

P607 HLA-DQA1*05 Allele Carriage and Anti-TNF Therapy Persi..:

Doherty, J ; Ryan, A ; Quinn, E...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i734-i735 , 2023

Link: https://doi.org/10.1093/..

11

P249 Colonic Explant Lactate Concentration and Disease Prog..:

McShane, C ; Corcoran, R ; O'Connell, F...
Journal of Crohn's and Colitis. 17 (2023) Supplement_1 - p. i399-i400 , 2023

Link: https://doi.org/10.1093/..

12

P452 Tofacitinib Effectiveness and Safety as Therapy for Ul..:

McNally, M ; Keating, E ; Gray, E...
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i431-i431 , 2022

Link: https://doi.org/10.1093/..

13

Association Between Ex Vivo Human Ulcerative Colitis Explan..:

Corcoran, R. M. ; MacDonagh, P. ; O'Connell, F....
Digestive Diseases and Sciences. 67 (2022) 12 - p. 5540-5550 , 2022

Link: https://doi.org/10.1007/..

14

P102 Changes in serum immune protein profiles following ved..:

O'Connell, J ; O'Connell, F ; O'Sullivan, J.
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i198-i199 , 2022

Link: https://doi.org/10.1093/..

15

P426 Association Between vedolizumab therapy outcome and Pr..:

McCormick, E ; Singh, P ; Kevans, D
Journal of Crohn's and Colitis. 16 (2022) Supplement_1 - p. i411-i412 , 2022

Link: https://doi.org/10.1093/..